Corpus Intelligence IC Memo — CHARLESTON SURGICAL HOSPITAL 2026-04-26 03:50 UTC
IC Memo — CHARLESTON SURGICAL HOSPITAL
Investment Committee Memorandum | WV | 7 beds | Grade D | EBITDA uplift $2.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHARLESTON SURGICAL HOSPITAL

CCN 510091 | KANAWHA, WV | 7 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CHARLESTON SURGICAL HOSPITAL is a 7-bed community hospital in KANAWHA, WV with $35.7M in net patient revenue and a 17.7% operating margin. The hospital serves a payer mix of 26.8% Medicare, 0.0% Medicaid, and 73.2% commercial.

Thesis: Turnaround. Our ML models identify $2.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 17.7% to 25.0% (+736bps).

Net Revenue HCRIS$35.7M
Current EBITDA COMPUTED$6.3M
Operating Margin COMPUTED17.7%
Occupancy HCRIS12.3%
Revenue / Bed COMPUTED$5.1M
Net-to-Gross HCRIS49.4%
Distress Probability MLnan%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
193
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 17.7% places it above the state median. Among 193 size-comparable peers (4-14 beds), the median margin is -11.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (4-14), prioritizing same-state peers. 193 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHARLESTON SURGICAL HOSPITAL (Target)WV7$35.7M17.7%
WENATCHEE VALLEY HOSPITALWA11$277.5M-4.9%
NATIONAL JEWISH HEALTHCO13$150.4M-50.0%
FRANCISCAN HEALTH HAMMONDIN10$117.7M-4.3%
OAK LEAF SURGICAL HOSPITAL LLCWI13$109.8M34.1%
JEWISH HOME FOR THE AGEDCA13$88.0M-48.0%
OCONTO HOSPITAL & MEDICAL CENTWI10$80.4M1.1%
SUMMIT PACIFIC MEDICAL CENTERWA10$73.6M9.1%
MEE MEMORIAL HOSPITALCA13$67.6M3.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$749K+210bp18mo
Cost to Collect4.5%2.5%$714K+200bp12mo
Denial Rate Reduction12.0%6.5%$706K+198bp12mo
A/R Days Reduction5200.0%3800.0%$434K+122bp9mo
Clean Claim Rate88.0%96.0%$23K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$749K
Cost to Collect
$714K
Denial Rate Reduction
$706K
A/R Days Reduction
$434K
Clean Claim Rate
$23K
Total EBITDA Uplift$2.6M
Current EBITDA$6.3M
+ RCM Uplift+$2.6M
Pro Forma EBITDA$8.9M
Current Margin17.7%
Pro Forma Margin25.0%
WC Released (1x)$1.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$9.7M$67.9M6.99x47.5%
Base (11x exit)10.0x11.0x$9.7M$77.8M8.02x51.6%
Bull Case9.0x11.0x$8.7M$89.6M10.26x59.3%
Bull (12x exit)9.0x12.0x$8.7M$100.4M11.49x62.9%
Bear Case11.0x10.0x$10.7M$51.6M4.83x37.0%
Bear (11x exit)11.0x11.0x$10.7M$60.2M5.64x41.3%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 12.3%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 193 hospitals with 4-14 beds
  • Same-state prioritization (n=5)
  • Comp margins: P25=-24.3% / P50=-11.0% / P75=2.6%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.